# Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder

> **NCT01280305** · PHASE3 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** raloxifene
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01280305
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2012-12
- **Final completion:** 2013-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2011-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01280305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01280305, "Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01280305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*